Chlorthalidone Tablet Dissolution Injury Lawsuit Lawyers

Chlorthalidone Recall Lawsuit Investigation: Thousands of Blood Pressure Medication Bottles Recalled Nationwide for Failed Dissolution Specifications.

What Parker Waichman LLP Found

• The FDA announced a nationwide recall involving 11,460 bottles of Chlorthalidone 25 mg tablets.
• The recall was initiated because the medication failed dissolution specifications.
• This is the second blood pressure medication recall announced within one month.
• Failed dissolution testing may interfere with proper medication delivery.
• Patients who suffered complications after taking recalled medications may have legal rights.

Millions of Americans depend on prescription medications every day to control serious health conditions that can become life-threatening if left untreated. High blood pressure medications are among the most commonly prescribed drugs in the United States because uncontrolled hypertension significantly increases the risk of heart attacks, strokes, kidney disease, and other cardiovascular complications. When a medication fails to meet manufacturing standards, patients may unknowingly lose access to the consistent treatment they rely upon to protect their health.

The U.S. Food and Drug Administration recently announced a nationwide recall involving 11,460 bottles of Chlorthalidone Tablets, USP, 25 mg. According to the recall information, the products were removed from distribution because they failed dissolution specifications.

The recalled medication was manufactured by Inventia Healthcare Limited in India and distributed in the United States by Rising Pharma Holdings Inc., headquartered in East Brunswick, New Jersey.

The recall affects both 100-count and 1,000-count bottles that were distributed nationally. Patients may have received these medications through retail pharmacies, mail-order pharmacies, hospital systems, long-term care facilities, and other healthcare providers.

This development is particularly noteworthy because it marks the second nationwide blood pressure medication recall announced within a single month. The timing may raise additional concerns about pharmaceutical manufacturing quality control, especially for medications used to treat chronic conditions requiring long-term daily use.

For patients who depend on blood pressure medication every day, any interruption in therapy or inconsistency in dosing can create serious health concerns.

What Is Chlorthalidone And Why Is It Prescribed?

Chlorthalidone is a prescription medication commonly used to treat hypertension, also known as high blood pressure. It belongs to a class of medications known as thiazide-like diuretics.

Many people refer to these medications as “water pills” because they help the body remove excess salt and water through increased urination.

Physicians prescribe Chlorthalidone because lowering blood pressure can significantly reduce the risk of serious cardiovascular events.

Chlorthalidone is often used to:

• Lower high blood pressure
• Reduce the risk of stroke
• Decrease the risk of heart attack
• Help manage fluid retention
• Improve long-term cardiovascular health

Hypertension itself is often called a silent disease because many individuals experience no symptoms for years while damage gradually occurs throughout the body.

When blood pressure remains elevated over time, it can damage:

• The heart
• The brain
• The kidneys
• The eyes
• Blood vessels throughout the body

Because hypertension requires long-term management, patients often take these medications continuously for years or decades. That reality makes medication consistency extremely important.

What Does “Failed Dissolution Specifications” Mean?

The reason for this recall centers on a manufacturing quality issue known as failed dissolution specifications. Most consumers have never heard this term before, but it represents a critical component of medication safety and effectiveness.

Dissolution refers to how quickly and efficiently a medication dissolves inside the body after ingestion. Prescription drugs are carefully designed to release active ingredients at specific rates so patients receive the intended therapeutic effect.

During manufacturing, pharmaceutical companies perform extensive testing to ensure every batch dissolves properly under standardized conditions. If a medication fails dissolution testing, several problems may occur.

The drug may:

• Dissolve too slowly
• Dissolve too quickly
• Fail to release the correct amount of medication
• Deliver inconsistent doses
• Reduce treatment effectiveness

Patients may unknowingly receive less medication than prescribed even though they are taking the medication exactly as directed. This can be especially dangerous for medications treating chronic cardiovascular conditions.

The FDA has not yet identified specific injuries associated with this recall. However, failed dissolution specifications create concerns because inconsistent drug delivery may interfere with disease management. For blood pressure patients, inadequate medication absorption could potentially contribute to uncontrolled hypertension.

Why Blood Pressure Medication Quality Matters

Blood pressure medications are not optional medications for many patients. They are essential therapies that help control one of the leading contributors to cardiovascular disease. When hypertension is not adequately controlled, the consequences can become severe.

Uncontrolled blood pressure may increase the risk of:

• Stroke
• Heart attack
• Congestive heart failure
• Kidney failure
• Aortic aneurysm
• Vision loss
• Peripheral artery disease

Some patients are particularly vulnerable to treatment interruptions.

Higher-risk populations include:

• Elderly individuals
• Patients with diabetes
• Patients with prior strokes
• Patients with heart disease
• Patients with chronic kidney disease

These individuals often rely heavily on maintaining stable blood pressure levels every day. Even temporary disruptions may create unnecessary health risks.

Patients should never stop taking blood pressure medication abruptly without consulting their physician. Instead, patients who discover they possess recalled medication should immediately contact their pharmacist or prescribing provider to discuss replacement options.

A Second Blood Pressure Medication Recall In One Month Raises Additional Questions

The Chlorthalidone recall follows another nationwide recall announced just weeks earlier involving Amlodipine and Olmesartan Medoxomil tablets. That earlier recall affected 15,696 bottles distributed nationally. The FDA stated that those medications also failed dissolution specifications because Olmesartan Medoxomil content fell below acceptable standards. That medication was manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories LLC in New Jersey.

While the recalls involve different manufacturers and distributors, the timing may raise broader concerns regarding pharmaceutical supply chain oversight and manufacturing quality control. Many generic medications sold throughout the United States are manufactured overseas. Foreign manufacturing facilities are subject to FDA oversight, but recalls occasionally reveal deficiencies that can affect medications already distributed to consumers.

Patients often assume medications reaching pharmacy shelves have undergone flawless production processes. While pharmaceutical manufacturing is highly regulated, recalls demonstrate that quality issues can still occur.

Multiple recalls within a short period often increase public scrutiny regarding:

• Manufacturing consistency
• Batch testing procedures
• Quality assurance protocols
• Regulatory oversight
• Supply chain management

Potential Health Risks Patients Should Monitor

The FDA has not yet identified specific adverse health events associated with the recalled Chlorthalidone medication. However, patients should remain attentive to symptoms that may indicate worsening blood pressure control.

Potential warning signs include:

• Headaches
• Dizziness
• Blurred vision
• Chest pain
• Shortness of breath
• Fatigue
• Confusion
• Irregular heartbeat

Some patients may experience no symptoms at all despite dangerously elevated blood pressure readings. For that reason, individuals taking blood pressure medication should continue monitoring their blood pressure regularly. Anyone experiencing concerning symptoms should contact a healthcare provider immediately.

Patients should also maintain records regarding:

• Prescription fill dates
• Pharmacy information
• Medication bottles
• Lot numbers
• Medical appointments
• Blood pressure readings

This documentation may become important if future investigations uncover additional information.

Product Liability Lawsuits Involving Defective Medications

Pharmaceutical companies have a legal responsibility to manufacture medications that meet established safety and quality standards. When defective drugs reach consumers, injured patients may have legal rights under product liability laws. Drug-related litigation often focuses on several legal theories.

Potential claims may include:

• Manufacturing Defects -Manufacturing defect claims arise when errors occur during production that render medications unsafe or ineffective.
• Negligence – Negligence claims may allege that reasonable quality control procedures were not followed during manufacturing, testing, or distribution.
• Failure To Warn – Manufacturers may have obligations to communicate known risks promptly when problems are identified.
• Breach Of Warranty – Consumers expect medications to perform as intended. Product failures may create breach of warranty claims under certain circumstances.

Every case depends upon individual facts, including whether a patient suffered measurable harm connected to the defective medication.

What Patients Should Do If They Possess Recalled Chlorthalidone

Patients should not panic if they discover they possess recalled medication. However, they should act promptly.

Recommended steps include:

• Check medication labels and lot numbers.
• Contact the pharmacy that dispensed the medication.
• Speak with the prescribing physician.
• Obtain replacement medication if necessary.
• Continue monitoring blood pressure.
• Preserve the medication bottle and packaging.
• Keep all receipts and pharmacy records.

Patients should never discontinue prescribed blood pressure medication without medical guidance. Maintaining continuity of care remains extremely important.

Contact Parker Waichman LLP For A Free Case Review

Prescription medications are intended to protect patients, not expose them to unnecessary risks caused by manufacturing defects or quality control failures.

If you or a loved one suffered serious health complications after taking recalled Chlorthalidone, Amlodipine, Olmesartan Medoxomil, or another defective blood pressure medication, you may have legal rights.

Parker Waichman LLP is actively investigating claims involving defective medications and pharmaceutical manufacturing failures nationwide. Our attorneys help injured patients pursue compensation for medical expenses, lost wages, pain and suffering, and other damages related to defective drugs.

Call Parker Waichman LLP today for a free consultation at 1-800-YOUR-LAWYER (1-800-968-7529). Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.

There are no fees unless compensation is recovered.